Condition: Monkeypox · Sponsor: Miquel Ekkelenkamp
The goal of this randomized controlled double-blind clinical trial is to test the drug tecovirimat in patients with mpox (previously known as monkeypox) disease. The main questions it aims to answer are: * Is tecovirimat effective in treating mpox infection. * Is tecovirimat safe to treat patients with mpox infection. Participants will receive either the drug tecovirimat orally, 600 mg twice per day, or a matching placebo. The outcome of the infection and the side effect experienced will be compared between the two groups.
This description comes directly from the study's public registry record.
Miquel B Ekkelenkamp, MD, PhD · +31643217087 · m.ekkelenkamp@umcutrecht.nl
Lina Gurskaite · +31631117890 · lina.gurskaite@ecraid.eu
Always discuss trial participation with your own doctor first.
| Institute of Tropical Medicine | Antwerp, Antwerp, Belgium | Recruiting |
| Cliniques Universitaires St. Luc | Brussels, Belgium | Not Yet Recruiting |
| APHP St. Louis | Paris, France | Not Yet Recruiting |
| Universitätsklinikum Bonn | Bonn, Germany | Not Yet Recruiting |
| Hospital Luigi Sacco | Milan, Italy | Not Yet Recruiting |
| Azienda Ospedaliera Universitaria Integrata Verona - AOUI Verona | Verona, Italy | Not Yet Recruiting |
| Amsterdam UMC - AMC | Amsterdam, Netherlands | Not Yet Recruiting |
| Oslo Unversity Hospital | Oslo, Norway | Not Yet Recruiting |
| Hospital de Santo António dos Capuchos | Lisbon, Portugal | Not Yet Recruiting |
| Hospital Clinico San Carlos | Madrid, Spain | Not Yet Recruiting |
| Hospital Universitario La Paz | Madrid, Spain | Not Yet Recruiting |
| Hospital Universitario Virgen Macarena | Seville, Spain | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06156566